1.Epidemiology and clinical features of acute hepatitis A: from the domestic perspective.
The Korean Journal of Hepatology 2009;15(4):438-445
Acute viral hepatitis A has recently become a major public health problem in Korea, and the incidence of symptomatic hepatitis A is growing rapidly. With improvements in socioeconomic conditions and environmental hygiene, the chances of exposure to hepatitis A virus (HAV) during childhood have decreased and, in turn, the proportion of young adults with positive anti-HAV has significantly decreased. This has led to the incidence of symptomatic acute hepatitis A increasing since the late 1990s. The incidence of serious complications including fulminant hepatic failure and acute kidney injury has also showed an increasing trend. Variation of the genotype of virus isolated from recent hepatitis A patients suggests an inflow of the hepatitis virus from other countries. In this review article, we present the situation and epidemiology of hepatitis A in Korea, and recommend further investigation and policies for vaccination on a national level.
Acute Disease
;
Genotype
;
Hepatitis A/complications/diagnosis/*epidemiology
;
Hepatitis A Antibodies/analysis
;
Humans
;
Incidence
;
Kidney Failure, Acute/etiology
;
Liver Failure, Acute/etiology
;
Vaccines, Inactivated/pharmacology
2.Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.
Yun Jung CHOI ; Jeong Han KIM ; Ja Kyung KOO ; Cho I LEE ; Ji Young LEE ; Jae Hoon YANG ; Soon Young KO ; Won Hyeok CHOE ; So Young KWON ; Chang Hong LEE
Clinical and Molecular Hepatology 2014;20(2):185-191
BACKGROUND/AIMS: A revised classification system for renal dysfunction in patients with cirrhosis was proposed by the Acute Dialysis Quality Initiative and the International Ascites Club Working Group in 2011. The aim of this study was to determine the prevalence of renal dysfunction according to the criteria in this proposal. METHODS: The medical records of cirrhotic patients who were admitted to Konkuk University Hospital between 2006 and 2010 were reviewed retrospectively. The data obtained at first admission were collected. Acute kidney injury (AKI) and chronic kidney disease (CKD) were defined using the proposed diagnostic criteria of kidney dysfunction in cirrhosis. RESULTS: Six hundred and forty-three patients were admitted, of whom 190 (29.5%), 273 (42.5%), and 180 (28.0%) were Child-Pugh class A, B, and C, respectively. Eighty-three patients (12.9%) were diagnosed with AKI, the most common cause for which was dehydration (30 patients). Three patients had hepatorenal syndrome type 1 and 26 patients had prerenal-type AKI caused by volume deficiency after variceal bleeding. In addition, 22 patients (3.4%) were diagnosed with CKD, 1 patient with hepatorenal syndrome type 2, and 3 patients (0.5%) with AKI on CKD. CONCLUSIONS: Both AKI and CKD are common among hospitalized cirrhotic patients, and often occur simultaneously (16.8%). The most common type of renal dysfunction was AKI (12.9%). Diagnosis of type 2 hepatorenal syndrome remains difficult. A prospective cohort study is warranted to evaluate the clinical course in cirrhotic patients with renal dysfunction.
Acute Kidney Injury/*epidemiology/etiology/mortality
;
Adult
;
Aged
;
Cohort Studies
;
Female
;
Hospital Mortality
;
Humans
;
Kidney Failure, Chronic/*epidemiology/etiology/mortality
;
Liver Cirrhosis/complications/*diagnosis
;
Male
;
Middle Aged
;
Prevalence
;
Prospective Studies
;
Severity of Illness Index
;
Survival Rate
3.Clinical Characteristics and Outcomes of Acute Hepatitis A in Korea: A Nationwide Multicenter Study.
So Young KWON ; Sang Hoon PARK ; Jong Eun YEON ; Sook Hyang JEONG ; Oh Sang KWON ; Jin Woo LEE ; Hong Soo KIM ; Yeon Seok SEO ; Young Seok KIM ; Joo Hyun SOHN ; Hyung Joon YIM ; Jong Young CHOI ; Myung Seok LEE ; Young Oh KWEON ; Jae Youn CHEONG ; Haak Cheoul KIM ; Heon Ju LEE ; Soon Koo BAIK ; Hyonggin AN ; Kwan Soo BYUN
Journal of Korean Medical Science 2014;29(2):248-253
The aim of this study was to investigate the clinical characteristics of acute hepatitis A during a recent outbreak in Korea. Data of patients diagnosed with acute hepatitis A from 2007 to 2009 were collected from 21 tertiary hospitals retrospectively. Their demographic, clinical, and serological characteristics and their clinical outcomes were analyzed. A total of 4,218 patients (mean age 33.3 yr) were included. The median duration of admission was 9 days. The mean of the highest ALT level was 2,963 IU/L, total bilirubin was 7.3 mg/dL, prothrombin time INR was 1.3. HBsAg was positive in 3.7%, and anti-HCV positive in 0.7%. Renal insufficiency occurred in 2.7%, hepatic failure in 0.9%, relapsing hepatitis in 0.7%, and cholestatic hepatitis in 1.9% of the patients. Nineteen patients (0.45%) died or were transplanted. Complications of renal failure or prolonged cholestasis were more frequent in patients older than 30 yr. In conclusion, most patients with acute hepatitis A recover uneventfully, however, complication rates are higher in patients older than 30 yr than younger patients. Preventive strategies including universal vaccination in infants and active immunization of hepatitis A to adult population should be considered for prevention of community-wide outbreaks of hepatitis A in Korea.
Acute Disease
;
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Child
;
Child, Preschool
;
Cholestasis/epidemiology/etiology
;
Demography
;
Hepatitis A/complications/*diagnosis/mortality
;
Humans
;
Kidney Failure, Chronic/epidemiology/etiology
;
Liver Transplantation
;
Middle Aged
;
Morbidity
;
Republic of Korea
;
Retrospective Studies
;
Tertiary Care Centers
;
Young Adult
4.Factors influencing the severity of acute viral hepatitis A.
Joo Il KIM ; Yun Soo KIM ; Young Kul JUNG ; Oh Sang KWON ; Yeon Suk KIM ; Yang Suh KU ; Duck Joo CHOI ; Ju Hyun KIM
The Korean Journal of Hepatology 2010;16(3):295-300
BACKGROUND/AIMS: Most patients with acute viral hepatitis A have a favorable course, but a few of them suffer from severe forms of hepatitis such as fulminant hepatitis. This study was carried out to identify the factors influencing the severity of acute viral hepatitis A. METHODS: We retrospectively reviewed the medical records of 713 patients with acute hepatitis A, who were divided into two groups: severe hepatitis A (N=87) and non-severe hepatitis A (N=626). Severe hepatitis was defined as fulminant hepatitis or prolongation of prothrombin time (INR> or =1.5). Clinical variables were compared between the two groups. RESULTS: The incidence of fulminant hepatitis was 1.4 % (10/713) in patients with acute hepatitis A. Thirty-three (4.6 %) cases exhibited HBsAg positivity. In multivariate analyses, significant alcohol intake and the presence of HBsAg were significant predictive factors of fulminant hepatitis A, and significant alcohol intake and age were significant predictive factors of severe hepatitis A. HBeAg and HBV-DNA status did not affect the clinical course of hepatitis A in chronic hepatitis B carriers. CONCLUSIONS: While most patients with acute hepatitis A have an uncomplicated clinical course, our data suggest that a more-severe clinical course is correlated with being older, significant alcohol intake, and chronic hepatitis-B-virus infection. (
Acute Disease
;
Adult
;
Age Factors
;
Alcohol Drinking
;
Female
;
Hepatitis A/complications/*diagnosis
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B, Chronic/complications
;
Humans
;
Liver Failure, Acute/epidemiology/etiology
;
Male
;
Middle Aged
;
Predictive Value of Tests
;
Prothrombin Time
;
Retrospective Studies
;
Severity of Illness Index
5.Incidence and Risk Factors of Acute Hepatic Failure after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Sang Hoon JEON ; Kyung Sik PARK ; Young Hwan KIM ; Yo Sig SHIN ; Min Kyoung KANG ; Byoung Kuk JANG ; Woo Jin CHUNG ; Kwang Bum CHO ; Jae Seok HWANG
The Korean Journal of Gastroenterology 2007;50(3):176-182
BACKGROUND/AIMS: Although transcatheter arterial chemoembolization (TACE) is a major treatment modality for unresectable hepatocellular carcinoma (HCC), acute hepatic failure after TACE is not rare. However, reports dealing with this important complication are not good enough and results are often variable. The purpose of this study was to evaluate the incidence and associated risk factors of acute hepatic failure after TACE. METHODS: From January 2001 to November 2004, six hundred and thirtytwo TACE sessions were performed in 377 patients (294 men and 83 women). Adriamycin mixed lipiodol solution and gelfoam were used for TACE. Various clinical and radiological factors before and after the procedure were reviewed retrospectively. Univariate and multivariate analyses were performed to evaluate the risk factors associated with the development of acute hepatic failure after TACE. RESULTS: Acute hepatic failure occurred in 76 (12.0%) of the 632 TACE sessions within 14 days. Univariate analysis revealed that Child-Pugh class, 1st TACE, total bilirubin level, number of involved segments, total size of tumor, presence of right portal vein thrombosis (PVT) or main PVT, involvement of segment 1, 5, 6, 7, modified UICC stage, and doses of chemotherapeutic agent were significantly different between the patients with or without hepatic failure after TACE. Among them, elevated total bilirubin (p=0.001, E (beta)=1.449), presence of right (p=0.035, E (beta)=2.109) or main (p=0.011, E (beta)=4.067) PVT were independently associated factors in multivariate analysis. CONCLUSIONS: The incidence of acute hepatic failure after TACE was 12.0%. Elevated bilirubin level and portal vein thrombosis could be considered as the predictive factors for acute hepatic failure after TACE in HCC patients.
Adult
;
Aged
;
Aged, 80 and over
;
Antibiotics, Antineoplastic/adverse effects/therapeutic use
;
Carcinoma, Hepatocellular/complications/pathology/*therapy
;
Chemoembolization, Therapeutic/*adverse effects/methods
;
Doxorubicin/adverse effects/therapeutic use
;
Female
;
Humans
;
Incidence
;
Iodized Oil/adverse effects/therapeutic use
;
Liver Failure, Acute/epidemiology/*etiology
;
Liver Function Tests
;
Liver Neoplasms/complications/pathology/*therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Predictive Value of Tests
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
6.Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Byoung Kuk JANG ; Seung Hyun LEE ; Woo Jin CHUNG ; Kyung Sik PARK ; Kwang Bum CHO ; Jae Seok HWANG ; Young Hwan KIM ; Jin Soo CHOI ; Jung Hyeok KWON
The Korean Journal of Hepatology 2008;14(2):168-177
BACKGROUND/AIMS: Transcatheter arterial chemoembolization (TACE) is a major modality in the treatment of unresectable hepatocellular carcinoma. Acute renal failure (ARF) may occur after TACE because of underlying liver cirrhosis and the presence of radiocontrast agent. However, the data available regarding this complication are variable and limited. The aim of this study was to determine the incidence and associated risk factors of ARF after TACE. METHODS: From January 2001 to December 2004, a total of 632 procedures were performed in 377 patients. Of these, the cases with high creatinine levels (> or = 2 mg/dL) before TACE and with incomplete medical records were excluded, which resulted in 463 procedures in 319 patients (256 males and 63 females; age 58.7+/-9.9 years, mean+/-SD) being examined for this study. Various clinical and radiological data before and after the procedure were reviewed retrospectively. RESULTS: ARF occurred following 15 (3.2%) of the 463 procedures within 7 days of TACE. Univariate analysis revealed that serum albumin levels (P=0.025), Model for End-Stage Liver Disease score (P=0.001), the distribution of Child-Pugh class (P=0.027), and the proportions of patients with ascites (P<0.001), using diuretics (P=0.010), and with a serum creatinine level > or = 1.5 mg/dL (P=0.023) differed significantly between patients with or without ARF after TACE. In multivariate analysis, the presence of ascites (P=0.005; odds ratio, 5.297) and serum creatinine level > or = 1.5 mg/dL (P=0.007; odds ratio, 7.358) were independently associated with the development of ARF. CONCLUSIONS: The incidence of ARF after TACE was 3.2%, and the presence of ascites and an abnormal baseline serum creatinine level were the risk factors for ARF.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Hepatocellular/complications/radiography/*therapy
;
Chemoembolization, Therapeutic/*adverse effects/mortality
;
Creatinine/blood
;
Female
;
Humans
;
Incidence
;
Kidney Failure, Acute/*epidemiology/etiology
;
Liver Neoplasms/complications/radiography/*therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Retrospective Studies
;
Risk Factors
;
Severity of Illness Index
;
Survival Analysis
7.Analysis of prognostic factors for patients with acute-on-chronic liver failure.
Xiao-yan LIU ; Jin-hua HU ; Hui-fen WANG
Chinese Journal of Hepatology 2009;17(8):607-610
OBJECTIVETo analyze the prognostic factors for patients with acute-on-chronic liver failure, and to build a scoring system for assessment of the prognosis of liver failure.
METHODS480 patients with acute-on-chronic liver failure in our hospital from January 2006 to June 2008 were enrolled in this study. The patients were divided into improved group and deteriorated group. The clinical data were analyzed by using chi square test, independent-Samples T Test and Binary logistic regression.
RESULTSThe factors that significantly affected the prognosis of Acute-on-chronic Liver Failure included age, hepatitis or liver cirrhosis, Staging, Hyponatremias, alpha-fetoprotein (AFP), the prothrombin time activity (PTA), total bilirubin (TBil), creatinine (Cr), albumin (ALB) and Hepatic encephalopathy, ascites, alimentary tract hemorrhage (P less than 0.05, P less than 0.01). PTA, Hyponatremias, hepatitis or liver cirrhosis, Hepatic encephalopathy and alimentary tract hemorrhage were independent risk factors of prognosis.
CONCLUSIONPTA, Hyponatremias, hepatitis or liver cirrhosis, Hepatic encephalopathy and alimentary tract hemorrhage are important to build a scoring system to assess the prognosis of Acute-on-chronic Liver Failure and may be useful to guide clinical treatment.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers ; blood ; Child ; Child, Preschool ; Chronic Disease ; Female ; Hepatic Encephalopathy ; complications ; Hepatitis, Viral, Human ; complications ; epidemiology ; Humans ; Hyponatremia ; complications ; Infant ; Liver Failure, Acute ; blood ; etiology ; pathology ; Logistic Models ; Male ; Middle Aged ; Prognosis ; Prothrombin Time ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Young Adult